Vectron Biosolutions
Trondheim, Norway vectronbiosolutions.com From their website, Nov 2026
Work here? Claim this listing
About
Vectron Biosolutions develops tailor-made microbial protein production strains and expression vectors for companies and research groups. It works mainly with bacterial systems, especially E. coli, from its headquarters in Trondheim, Norway. The company serves life science customers across pharma, industrial enzymes, and academic applications.
Services
Feasibility and Strategy assessment
Evaluates expression options such as plasmid copy number, signal peptides, fusion partners, expression strength, and chaperones to define a first-generation production strain.
Cell line development
Optimization of Genetics
Optimizes genetic elements such as expression strength and plasmid copy number to improve the production strain.
Cell line development
Cultivation optimization & Scale-up
Screens host strain, medium, harvest timepoint, induction OD, and inducer concentration to define an optimized cultivation protocol and scale-up to HCDC.
Cell line development
Fed-batch optimization
Optimizes temperature, harvest time, feeding strategy, and fed-batch media to produce an optimized fed-batch protocol.
Cell line development
Research cell bank generation
Delivers a research cell bank with full documentation after development work.
Cell line development
Protein production process development
Develops bespoke bacterial protein production processes to maximize titers of biologically active protein.
Microbial secretion technology development
Develops microbial secretion solutions to move proteins out of the cell and reduce downstream issues.
Directed evolution of expression vectors
Creates and screens randomized expression vector libraries to find improved vector designs for soluble protein production.
2 more services
- Bacterial strain engineering
- Bioinformatics project services
- Turnaround
- Rapid (1-2 weeks) screening of millions of expression vector variants
Capabilities
- Assays and studies
- E. coli expression
- Peptides
- Feasibility studies
- Screening
- High cell-density fed-batch testing
- Directed evolution screening
- Scale and capacity
- Microtiter scale
- High cell-density fed-batch conditions
- Up to 60 g/L
- Therapeutic areas
- Pharma
- Academic research
- Synthetic biology
Instruments and platforms
- Microtiter scale screening platform
Modalities and species
- Modalities
- Peptide
- Recombinant protein
- Species and models
- E. coli
- E. coli K strains
- E. coli B strains
- Other bacteria
Industries served
- Industrial enzymes
Details
- Type
- CRDMO
- Founded
- 2008
- Based in
- Trondheim, Norway
- Serves
- Life science industries